Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |